M
A
L
I
G
N
A
N
T
|
1
|
80
|
Re-Staging
|
Node
|
1.9
|
Minimal PSMA expression in left pelvic node
|
Known metastatic PCa with bony metastases but no other nodal disease and expression much lower than bone metastases.
|
Further investigation not pursued due to lesions elsewhere and treated as PCa nodal metastasis
|
2
|
69
|
Initial Staging
|
Node
|
2.4
|
Multiple bilateral prominent iliac nodes up to 12mm, much lower expression than primary.
|
No confirmation.
|
Commenced on ADT.
|
3
|
76
|
BCR post RP
|
Lung
|
1.7
|
11mm ground glass nodule within LUL.
|
Likely synchronous primary lung Ca.
|
Follow up CT in 3 months advised. No follow up at STV.
|
4
|
95
|
Initial Staging
|
Lung
|
2.1
|
19mm spiculated lung nodule in RUL.
|
Likely synchronous primary lung Ca.
|
No follow up given age and comorbidities.
|
5
|
72
|
BF post RP
|
Lung
|
4.2
|
Irregular 14mm pulmonary lesion RUL
|
Likely primary lung adenocarcinoma
|
No follow up.
|
6
|
83
|
Re-Staging
|
Lung
|
1.3
|
10mm RLL ground glass pulmonary nodule.
|
Uncertain significance, possible lung primary.
|
Stable on follow up CT (4 months). Ongoing follow up.
|
7
|
65
|
Initial Staging
|
Skin
|
2.1
|
10mm right thigh lesion.
|
No evidence of primary or metastatic prostate cancer
|
No follow up as widespread metastases from separate neuroendocrine tumour
|
8
|
75
|
Re-Staging
|
Bladder
|
N/A*
|
Right VUJ lesion.
|
Primary bladder tumour.
|
No follow up, patient resident abroad and left New Zealand
|
9
|
81
|
Initial Staging
|
Lung
|
2.7
|
Low PSMA expression in 11mm nodule within RUL
|
Likely primary lung adenocarcinoma.
|
No follow up given comorbidities and age.
|
10
|
73
|
Initial Staging
|
Node
|
2.1
|
Low PSMA expression in 14mm mesenteric node
|
High expression in prostate and pelvic node considered typical for prostate cancer. Mesenteric node indeterminate.
|
Commenced on ADT with pelvic Radiotherapy. Awaiting further follow-up.
|
B
E
N
I
G
N
|
1
|
79
|
BF post RP
|
Lung
|
2.6
|
Low PSMA expression in LUL ground glass change
|
Likely inflammatory.
|
No follow up.
|
2
|
72
|
Initial Staging
|
Lung
|
4.9
|
Low PSMA expression in LUL ground glass change
|
Likely inflammatory.
|
No follow up.
|
3
|
84
|
BCR post RP
|
Liver
|
13.4
|
PSMA expression within segment 4 of the liver.
|
Image noise versus liver metastasis, not solid organ disease elsewhere
|
Not present on follow up PSMA with rising PSA. Most likely benign or artefact.
|
4
|
77
|
BCR post RP
|
Lung
|
2.2
|
Minimal PSMA expression in 12mm RUL lung nodule
|
Two sigmoid lesions FDG avid ?metastasis from bowel/prostate or benign lesion
|
Follow up CT 2 years later showed no significant change in lesion.
|
5
|
69
|
BCR post RP
|
Lung
|
1.6
|
Minimal PSMA expression in 9mm irregular pulmonary nodule
|
Solitary pelvic node recurrence. Indeterminate lung nodule.
|
No change on surveillance imaging for over 2 years.
|
6
|
76
|
BCR post RP
|
Kidney
|
< 1
|
30mm heterogeneous right retroperitoneal lesion abutting inferior pole of right kidney
|
Likely benign cyst or lymphatic lesion, exclude sarcoma.
|
Non-enhancing on dedicated triple phase CT and unchanged over 13 months.
|
7
|
79
|
BCR post RP
|
Bone
|
< 1
|
Low PSMA expression in left temporal bone.
|
Likely benign lesion.
|
No further imaging. Remained asymptomatic.
|
8
|
69
|
BCR post RP
|
Sinus
|
7.5
|
PSMA expression in left maxillary sinus mass.
|
Likely inflammatory, exclude tumour.
|
Follow up with ENT – CT/MRI demonstrating no suspicious lesion. Changes resolved on imaging 3 years later
|
9
|
70
|
Initial Staging
|
Bone
|
< 1
|
Right sacral alar lesion without significant expression, significant expression in primary
|
Indeterminate lesion, possibly benign.
|
FDG PET/CT 2 weeks later demonstrated no avidity. Follow up over 18 months no change
|
10
|
|
BCR post RP
|
Colon
|
< 1
|
Minimal PSMA expression within sigmoid colon.
|
Clinical and radiological evidence of diverticulitis.
|
Resolved. Subsequent PSMA PET/CT no uptake.
|
11
|
|
BCRP post RP
|
Lung
|
< 1
|
Minimal PSMA expression within the lung.
|
Likely rounded atelectasis.
|
Resolved on subsequent CT.
|
12
|
|
BCRP post RP
|
Larynx
|
< 1
|
Solid nodule within right false vocal cord.
|
Likely right laryngocele.
|
No progression with clinical surveillance.
|
13
|
67
|
BCR post RP
|
Spleen
|
13
|
Pelvic nodal recurrence with mild expression. 7mm hypodense splenic lesion
|
Indeterminate splenic lesion
|
Not suitable and patient reluctant for active treatment. Patient remains well over 4 years of clinic follow up.
|
14
|
61
|
BCR post RP
|
Retro-peritoneal
|
< 1
|
Thin walled cystic retro-peritoneal lesion.
|
Most likely benign.
|
Patient underwent salvage radiotherapy. No specific follow up of retroperitoneal lesion.
|
15
|
63
|
Initial Staging
|
Lung
|
4.2
|
18mm pleural based nodule
|
Likely benign.
|
Resolved on follow up CT 3 months later.
|
16
|
50
|
Initial Staging
|
Skin
|
3.2
|
Left paraspinal subcutaneous nodule with minimal PSMA expression.
|
Likely benign.
|
No change on follow up PSMA. No specific comment on follow up regarding skin lesion.
|
17
|
75
|
BCR post RP
|
Lung
|
< 1
|
Non-avid patchy opacity in LUL.
|
Likely inflammatory changes.
|
Follow up CT in 6 weeks advised. No follow up at STV.
|